2m 2m 2m 2m 2m 2m 2m
RECURSN PHARMA-A (RXRX)
NASDAQ
$3.20-$0.005 (-0.16%)
Price as of Sep 11, 2026 7:58 PM EDT- $1.7BMarket Cap
- -33.75%1-Year Change
- BiotechnologyIndustry
RECURSN PHARMA-A (RXRX)
$3.20-$0.005 (-0.16%)
RXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.20 | ||
Change | +$0.04 (+1.27%) | ||
Open | $3.21 | ||
High | $3.25 | ||
Low | $3.15 | ||
Previous Close | $3.16 | ||
Volume | 8,034,114 | ||
30-Day Average Volume | 15,175,203 | ||
1-Week Change | -11.85% | ||
1-Month Change | -4.48% | ||
1-Year Change | -33.75% | ||
3-Year Change | -61.58% | ||
5-Year Change | -88.69% | ||
Fundamentals | |||
Shares Outstanding | 535.3M | ||
Total Assets | $1.2B | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | $7.3M | ||
Net Income | -$131.0M | ||
Free Cash Flow | -$106.0M | ||
EBIT | -$131.0M | ||
EBITDA | -$112.8M | ||
Net Working Capital | $483.6M | ||
EPS | -$0.25 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 162 | ||
P/B | 2 | ||
P/E | -13 | ||
PEG | 1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue